These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
256 related items for PubMed ID: 22189255
1. Partially hydrolysed 100% whey-based infant formula and the prevention of atopic dermatitis: comparative pharmacoeconomic analyses. Spieldenner J, Belli D, Dupont C, Haschke F, Iskedjian M, Nevot Falcó S, Szajewska H, von Berg A. Ann Nutr Metab; 2011; 59 Suppl 1():44-52. PubMed ID: 22189255 [Abstract] [Full Text] [Related]
2. Economic evaluation of a 100% whey-based partially hydrolyzed infant formula in the prevention of atopic dermatitis among Swiss children. Iskedjian M, Belli D, Farah B, Navarro V, Detzel P. J Med Econ; 2012; 15(2):378-93. PubMed ID: 22171935 [Abstract] [Full Text] [Related]
3. Economic evaluation of a 100% whey-based partially hydrolyzed infant formula in the prevention of atopic dermatitis among Danish children. Iskedjian M, Haschke F, Farah B, van Odijk J, Berbari J, Spieldenner J. J Med Econ; 2012; 15(2):394-408. PubMed ID: 22171936 [Abstract] [Full Text] [Related]
4. Cost-effectiveness of partially-hydrolyzed formula for prevention of atopic dermatitis in Australia. Su J, Prescott S, Sinn J, Tang M, Smith P, Heine RG, Spieldenner J, Iskedjian M. J Med Econ; 2012; 15(6):1064-77. PubMed ID: 22630113 [Abstract] [Full Text] [Related]
5. Meta-analysis of a partially hydrolysed 100%-whey infant formula vs. extensively hydrolysed infant formulas in the prevention of atopic dermatitis. Iskedjian M, Szajewska H, Spieldenner J, Farah B, Berbari J. Curr Med Res Opin; 2010 Nov; 26(11):2599-606. PubMed ID: 20925453 [Abstract] [Full Text] [Related]
6. Economic evaluation of a 100% whey-based, partially hydrolysed formula in the prevention of atopic dermatitis among French children. Iskedjian M, Dupont C, Spieldenner J, Kanny G, Raynaud F, Farah B, Haschke F. Curr Med Res Opin; 2010 Nov; 26(11):2607-26. PubMed ID: 20925454 [Abstract] [Full Text] [Related]
7. Is prevention of atopic eczema with hydrolyzed formulas cost-effective? A health economic evaluation from Germany. Mertens J, Stock S, Lüngen M, von Berg A, Krämer U, Filipiak-Pittroff B, Heinrich J, Koletzko S, Grübl A, Wichmann HE, Bauer CP, Reinhardt D, Berdel D, Gerber A. Pediatr Allergy Immunol; 2012 Sep; 23(6):597-604. PubMed ID: 22624978 [Abstract] [Full Text] [Related]
9. Meta-analysis of the evidence for a partially hydrolyzed 100% whey formula for the prevention of allergic diseases. Szajewska H, Horvath A. Curr Med Res Opin; 2010 Feb; 26(2):423-37. PubMed ID: 20001576 [Abstract] [Full Text] [Related]
14. Infant formulas containing hydrolysed protein for prevention of allergic disease. Osborn DA, Sinn JK, Jones LJ. Cochrane Database Syst Rev; 2018 Oct 19; 10(10):CD003664. PubMed ID: 30338526 [Abstract] [Full Text] [Related]
15. WITHDRAWN: Infant formulas containing hydrolysed protein for prevention of allergic disease and food allergy. Osborn DA, Sinn JK, Jones LJ. Cochrane Database Syst Rev; 2017 May 25; 5(5):CD003664. PubMed ID: 28542713 [Abstract] [Full Text] [Related]
16. Infant formulas containing hydrolysed protein for prevention of allergic disease and food allergy. Osborn DA, Sinn JK, Jones LJ. Cochrane Database Syst Rev; 2017 Mar 15; 3(3):CD003664. PubMed ID: 28293923 [Abstract] [Full Text] [Related]